聚氨酸逆向高斯廷针头作为SARS-CoV-2感染的治疗工具
Carlos J Ciudad1, Simonas Valiuska1, José Manuel Rojas2
1Department of Biochemistry & Physiology, School Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain; Institut de Nanociencia i Nanotecnologia (IN2UB), Universitat de Barcelona, Barcelona, Spain.
The Journal of biological chemistry
|October 12, 2024
概括
聚氨酸逆针头 (PPRHs) 显示出作为抗病毒疗法对抗SARS-CoV-2的重大潜力. 这些分子有效地抑制了细胞培养中的病毒复制,并保护小鼠免受感染,突出显示了它们的治疗前景.
科学领域:
- 分子生物学分子生物学
- 病毒学 病毒学
- 抗菌研究 抗菌研究
背景情况:
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 仍然是一个全球健康问题,尽管世卫组织宣布COVID-19大流行不再是全球紧急情况.
- 基于寡核酸的疗法,包括反感性寡核酸 (ASO),小干扰RNA (siRNA) 和CRISPR系统,正在成为有前途的抗病毒策略.
- 聚氨酸反向钉头发针 (PPRHs) 之前已经被验证用于COVID-19诊断.
研究的目的:
- 调查特定的聚氨酸逆针头 (PPRH),即CC1-PPRH和CC3-PPRH,抑制SARS-CoV-2复制的潜力.
- 评估PPRHs与SARS-CoV-2基因组内的目标序列的结合亲和力.
- 评估PPRHs作为抗病毒剂对SARS-CoV-2的体外和体内疗效.
主要方法:
- 在SARS-CoV-2复制酶和尖端区域中合成和表征CC1-PPRH和CC3-PPRH向聚皮里米丁序列.
- 使用生物物理方法 (报告为nM顺序) 确定PPRHs与病毒RNA序列的结合亲和力.
- 在体外抗病毒试验中,涉及VERO-E6细胞与PPRHs的传染,随后感染SARS-CoV-2.
- 在体内研究中,使用K18-hACE2转基因小鼠在SARS-CoV-2挑战之前注射CC1-PPRH鼻入.
主要成果:
- 无论是CC1-PPRH还是CC3-PPRH,都表现出高结合亲和力 (nM范围) 与 SARS-CoV-2 基因组中的各自目标序列.
- 在体外,PPRHs在感染前24小时内在VERO-E6细胞中减少了超过92%的SARS-CoV-2病毒复制.
- 在K18-hACE2小鼠中注射CC1-PPRH导致了对SARS-CoV-2感染的完全保护.
结论:
- 在体外和体外模型中,聚氨酸逆头针 (PPRHs) 对SARS-CoV-2表现出强大的抗病毒活性.
- 高结合亲和力和显著减少病毒复制的位置PPRHs作为新型抗病毒疗法的有希望的候选人.
- PPRHs不仅代表SARS-CoV-2,也代表其他病毒感染的潜在治疗策略.
更多相关视频
08:33Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
8.9K
11:11Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
Published on: February 11, 2022
4.5K
相关概念视频
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
